FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? Garry G. GrahamRichard O. DayAnthoulla Mohamudally Research Article 07 March 2010 Pages: 47 - 55
Erratum to: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? Garry G. GrahamRichard O. DayAnthoulla Mohamudally Erratum 10 April 2010 Pages: 57 - 57
Relevance of Helicobacter pylori genotypes in gastric pathology and its association with plasma malondialdehyde and nitric oxide levels Santosh K. TiwariG. ManojAmrita Nandan Research Article 09 February 2010 Pages: 59 - 64
Synergism between COX-3 inhibitors in two animal models of pain J. MuñozC. NavarroH. F. Miranda Research Article 02 February 2010 Pages: 65 - 71
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn’s disease Lynn W. MainesLeo R. FitzpatrickCharles D. Smith Research Article 12 February 2010 Pages: 73 - 85
Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats Omar Mohamed E. Abdel SalamAmany A. SleemNermeen Shafee Research Article 14 January 2010 Pages: 87 - 94
Hungarian Experimental and Clinical Pharmacology Society Abstracts Abstracts 02 March 2010 Pages: 95 - 106